EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

RELEVANT LEGISLATION
Last updated 19 dubna 2024. Database contains 4821 unique substances/entries.
Filter the list

Strana 7   193
25 Položek na stránku
Zobrazení 151 - 175 z 4 821 výsledků.
Substance Name
EC No.
CAS No.
EU CLP (1272/2008)
EU_BA Directive 2000/54/EC
EU REACH: List of SVHC
(±)-1-methyl-4-(1-methylvinyl)cyclohexene;dipentene; limonene
205-341-0
138-86-3;7705-14-8
Flam. Liq. 3; Skin Irrit. 2; Skin Sens. 1
(±)-1-methyl-4-(1-methylvinyl)cyclohexene;dipentene; limonene
205-341-0
138-86-3;7705-14-8
Flam. Liq. 3; Skin Irrit. 2; Skin Sens. 1
(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin
430-730-9
-
Eye Dam. 1
(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride
PAYLEAN; RACTOPAMINE HYDROCHLORIDE
415-170-5
90274-24-1;99095-19-9
Acute Tox. 4; Skin Sens. 1
(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride
PAYLEAN; RACTOPAMINE HYDROCHLORIDE
415-170-5
90274-24-1;99095-19-9
Acute Tox. 4; Skin Sens. 1
(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
T001446
419-600-2
99199-90-3
Skin Sens. 1
(±)-butan-2-ol;butan-2-ol
201-158-5
15892-23-6;78-92-2
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
(±)-butan-2-ol;butan-2-ol
201-158-5
15892-23-6;78-92-2
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine
BRL 44742
415-550-0
109887-53-8
Acute Tox. 4; Eye Dam. 1
(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile
T001769
419-290-9
780757-44-0
Skin Sens. 1
(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate
CG 24-020; FERROCEN-SBF6
407-840-0
100011-37-8
Acute Tox. 4; Eye Dam. 1
(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate
CG 26-751
407-880-9
117549-13-0
Acute Tox. 4
1,1',1'-nitrilotripropan-2-ol; triisopropanolamine
204-528-4
122-20-3
Eye Irrit. 2
1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)
COMPIMIDE™ 121
405-840-5
110866-35-8
Skin Sens. 1
1,1'-dioxybiscyclohexan-1-ol [> 91 % solution];1,1'-dioxybiscyclohexan-1-ol [≤ 91 % solution]
219-306-2
2407-94-5
Org. Perox. A; Skin Corr. 1B; Acute Tox. 4
1,1'-dioxybiscyclohexan-1-ol [> 91 % solution];1,1'-dioxybiscyclohexan-1-ol [≤ 91 % solution]
219-306-2
2407-94-5
Org. Perox. C; Acute Tox. 4; Skin Corr. 1B
1,1'-iminodipropan-2-ol; di-isopropanolamine
203-820-9
110-97-4
Eye Irrit. 2
1,1,1,3,3-pentafluorobutane
430-250-1
406-58-6
Flam. Liq. 2
1,1,1-trichloroethane; methyl chloroform
200-756-3
71-55-6
Acute Tox. 4
1,1,2,2-tetrabromoethane
201-191-5
79-27-6
Acute Tox. 2; Eye Irrit. 2
1,1,2,2-tetrachloroethane
201-197-8
79-34-5
Acute Tox. 2; Acute Tox. 1
1,1,2-trichloroethane
201-166-9
79-00-5
Carc. 2; Acute Tox. 4
1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate
D 28-283
419-430-9
56533-00-7
Acute Tox. 4; STOT RE 2; Skin Corr. 1B
1,1,3,3-tetramethylbutylperoxypivalate
424-980-8
22288-41-1
Flam. Liq. 2; Org. Perox. D; Skin Irrit. 2; Skin Sens. 1
1,1-dichloro-1-nitroethane
209-854-0
594-72-9
Acute Tox. 3
Strana 7   193
25 Položek na stránku
Zobrazení 151 - 175 z 4 821 výsledků.

Export search results to: